MeVis Medical Solutions AG provided earnings guidance for the fiscal year ending September 30, 2022. For the year, the company expects to increase significantly to €17.5 million to €18.0 million (previous forecast for fiscal year 2021/2022: stable revenues of €16.0 million to €16.5 million). For EBIT (earnings before interest and taxes), the company is now expected to increase significantly to €6.0 million to €6.5 million (previous forecast for fiscal year 2021/2022: stable EBIT of €4.0 million to €4.5 million).

Reasons for the increased revenues are the positive business development with the customer Hologic both in the license and in the maintenance business and, in addition, the development services with various medical technology companies have also developed very positively.